US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liminatus Pharma LLC

9.48

-7.1200-42.89%

Post-market: 9.500.0184+0.19%19:59 EDT

Volume:684.27K

Turnover:7.76M

Market Cap:246.62M

PE:-69.55

High:17.55

Open:17.15

Low:9.00

Close:16.60

Loading ...

Overview Company News Filings

Liminatus Pharma Inc. Files Initial Statement of Beneficial Ownership, Naming KH Feelux Co., Ltd as 10% Owner

AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday

Liminatus Pharma files to sell 21.15M shares of common stock for holders

BRIEF-Liminatus Pharma Says Iba101 Advances Toward Human Trials In U.S.& Korea

Liminatus Pharma Inc - Iba101 Advances Toward Human Trials in U.S. and Korea - SEC Filing

THOMSON REUTERS

Liminatus Pharma Inc. Prepares for Clinical Trials of IBA101, Pioneering Next-Gen CD47 Inhibitor for Safer Cancer Immunotherapy

Liminatus Pharma Inc. Files Initial Statement of Beneficial Ownership; Valetudo Therapeutics LLC Named as Beneficial Owner

Liminatus Pharma Inc trading resumes

Top Premarket Gainers

MT Newswires Live

Liminatus Pharma Inc trading halted, volatility trading pause

Crude Oil Moves Higher; Ciena Posts Downbeat Earnings

Liminatus Pharma Inc trading halted, volatility trading pause

Liminatus Pharma Shares Jump 75.4% After More Than Doubling in Value in the Last Session

THOMSON REUTERS

Liminatus Pharma Shares Jump 80% Premarket After More Than Doubling in Value in the Last Session

THOMSON REUTERS

Stocks to Watch: Verint, Liminatus, Five Below

Liminatus Pharma Achieves Compliance with Nasdaq Filing Requirements Following Recent Delay

Liminatus Pharma Shares Halted; Last up 107.5% at $11

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LIMN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LIMN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LIMN\",,,,,undefined,":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":9.48,"timestamp":1751054400000,"preClose":16.6,"halted":0,"volume":684271,"hourTrading":{"tag":"盘后","latestPrice":9.4984,"preClose":9.48,"latestTime":"19:59 EDT","volume":36062,"amount":352373.8199,"timestamp":1751068752001},"delay":0,"floatShares":19874497,"shares":26014633,"eps":-0.136308,"marketStatus":"Market Closed","change":-7.12,"latestTime":"06-27 16:00:00 EDT","open":17.15,"high":17.55,"low":9,"amount":7756384.221292,"amplitude":0.51506,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.136308,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":16.6,"preHourTrading":{"tag":"盘前","latestPrice":17.5,"preClose":16.6,"latestTime":"09:29 EDT","volume":9174,"amount":166454.53301400002,"timestamp":1751030999999},"postHourTrading":{"tag":"盘后","latestPrice":9.4984,"preClose":9.48,"latestTime":"19:59 EDT","volume":36062,"amount":352373.8199,"timestamp":1751068752001},"volumeRatio":1.4346215137336475},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LIMN\",,,,,undefined,":{"symbol":"LIMN","floatShares":19874497,"roa":"-54.40%","roe":"--","lyrEps":-0.031598,"volumeRatio":1.4346215137336475,"shares":26014633,"dividePrice":0,"high":17.55,"amplitude":0.51506,"preClose":16.6,"low":9,"week52Low":4.4,"pbRate":"-232659.17","week52High":33.66,"institutionHeld":0,"latestPrice":9.48,"eps":-0.136308,"divideRate":0,"volume":684271,"delay":0,"ttmEps":-0.136308,"open":17.15,"prevYearClose":11.22,"prevWeekClose":14.43,"prevMonthClose":5.43,"prevQuarterClose":9,"fiveDayClose":14.43,"twentyDayClose":5.22,"sixtyDayClose":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LIMN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546722390","title":"Liminatus Pharma Inc. Files Initial Statement of Beneficial Ownership, Naming KH Feelux Co., Ltd as 10% Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2546722390","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546722390?lang=en_us&edition=fundamental","pubTime":"2025-06-28 06:16","pubTimestamp":1751062597,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has filed an initial statement of beneficial ownership, identifying KH Feelux Co., Ltd as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 27, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL2B8PpW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2546475312","title":"AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2546475312","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546475312?lang=en_us&edition=fundamental","pubTime":"2025-06-26 00:33","pubTimestamp":1750869223,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/06/46099614/aerovironment-posts-better-than-expected-earnings-joins-quantumscape-bumble-blackberry-and-other-big-stocks-moving-higher-on-wednesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TIGR","SYM","LNW","LIMN","AVAV","QS","TMC","KEP","YSG","NKTR","NNNN","BMBL","TTMI"],"gpt_icon":1},{"id":"2546255586","title":"Liminatus Pharma files to sell 21.15M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2546255586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546255586?lang=en_us&edition=fundamental","pubTime":"2025-06-25 04:55","pubTimestamp":1750798520,"startTime":"0","endTime":"0","summary":"16:51 EDT Liminatus Pharma (LIMN) files to sell 21.15M shares of common stock for holders Published first on TheFly – the ultimate source for real-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-files-to-sell-21-15m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-files-to-sell-21-15m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2546725835","title":"BRIEF-Liminatus Pharma Says Iba101 Advances Toward Human Trials In U.S.& Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2546725835","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546725835?lang=en_us&edition=fundamental","pubTime":"2025-06-25 03:42","pubTimestamp":1750794171,"startTime":"0","endTime":"0","summary":"BRIEF-Liminatus Pharma Says Iba101 Advances Toward Human Trials In U.S.& KoreaJune 24  - Liminatus Pharma Inc LIMN.O:LIMINATUS PHARMA INC - IBA101 ADVANCES TOWARD HUMAN TRIALS IN U.S. AND KOREA - SEC FILINGSource text: [ID:n0001104659-25-062058]Further company coverage: LIMN.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SR0Y3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2546410230","title":"Liminatus Pharma Inc - Iba101 Advances Toward Human Trials in U.S. and Korea - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2546410230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546410230?lang=en_us&edition=fundamental","pubTime":"2025-06-25 03:08","pubTimestamp":1750792129,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nFWN3SR0Y3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2546230467","title":"Liminatus Pharma Inc. Prepares for Clinical Trials of IBA101, Pioneering Next-Gen CD47 Inhibitor for Safer Cancer Immunotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2546230467","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546230467?lang=en_us&edition=fundamental","pubTime":"2025-06-25 03:04","pubTimestamp":1750791881,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. Prepares for Clinical Trials of IBA101, Pioneering Next-Gen CD47 Inhibitor for Safer Cancer Immunotherapy. Liminatus Pharma Inc., based in La Palma, California, has announced the advancement of its novel CD47 checkpoint inhibitor, IBA101, towards human trials in the United States and Korea. This development marks a significant step in the company's efforts to enhance immunotherapy options with a focus on safety and efficacy. IBA101 is engineered to avoid the anemia and thrombocytopenia issues that affected previous candidates, allowing for potentially higher dosing levels and improved anti-tumor responses. Liminatus is preparing its Investigational New Drug  applications for submission to the U.S. Food and Drug Administration and Korea's Ministry of Food and Drug Safety in the second half of 2026. The clinical trials are set to begin in early 2027, with a strategic collaboration established in Seoul, South Korea, to facilitate advanced research on non-small-cell l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDLb2bRMK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2544987644","title":"Liminatus Pharma Inc. Files Initial Statement of Beneficial Ownership; Valetudo Therapeutics LLC Named as Beneficial Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987644","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544987644?lang=en_us&edition=fundamental","pubTime":"2025-06-17 09:20","pubTimestamp":1750123203,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc. has filed an initial statement of beneficial ownership, identifying Valetudo Therapeutics LLC as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250617:nNDLbnMQ91:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2542746548","title":"Liminatus Pharma Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2542746548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542746548?lang=en_us&edition=fundamental","pubTime":"2025-06-12 22:50","pubTimestamp":1749739812,"startTime":"0","endTime":"0","summary":"10:47 EDT Liminatus Pharma (LIMN) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-inc-trading-resumes-thefly-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-inc-trading-resumes-thefly-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2542519397","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2542519397","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542519397?lang=en_us&edition=fundamental","pubTime":"2025-06-12 19:58","pubTimestamp":1749729505,"startTime":"0","endTime":"0","summary":"CureVac  shares were up 32% in recent Thursday premarket activity after the company and BioNTech  said they signed an agreement under which BioNTech will acquire CureVac in an all-stock deal.Liminatus Pharma  stock was 26% higher, shaving Wednesday's loss.Klotho Neurosciences  shares were 19% higher, erasing the previous session's fall.Oracle  stock was 9% higher, a day after the company reported higher fiscal Q4 non-GAAP earnings and revenue.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1815336760.USD","LU2054465674.USD","IE00B5949003.HKD","LU0661504455.SGD","LU0980610538.SGD","LU1366333091.USD","LU2326559502.SGD","LU0157215616.USD","IE00BLSP4239.USD","LU0433182093.SGD","IE00BMPRXN33.USD","LU0320765489.SGD","CVAC","LU1935043536.SGD","BNTX","LU0648001328.SGD","LU2360106780.USD","IE0004445239.USD","LU0081259029.USD","LU0444971666.USD","LU1691799644.USD","LU1429558221.USD","LU0130102774.USD","LU0056508442.USD","LU0476273544.USD","LU1934455863.HKD","BK4538","LU1506573853.SGD","LU1803068979.SGD","LU1934455277.USD","LU1069347547.HKD","LU1934455194.USD","IE00B3S45H60.SGD","LU0109392836.USD","LU0323591593.USD","LU0965509010.AUD","IE00B19Z3581.USD","BK4534","BK4528","BK4533","LU1642822529.SGD","BK4588","LIMN","LU0348723411.USD","IE0002270589.USD","LU1935043023.USD","IE00BBT3K403.USD","LU0738911758.USD"],"gpt_icon":1},{"id":"2542587207","title":"Liminatus Pharma Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2542587207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542587207?lang=en_us&edition=fundamental","pubTime":"2025-06-11 21:40","pubTimestamp":1749649206,"startTime":"0","endTime":"0","summary":"09:38 EDT Liminatus Pharma (LIMN) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, marke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-inc-trading-halted-volatility-trading-pause-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-inc-trading-halted-volatility-trading-pause-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2541600865","title":"Crude Oil Moves Higher; Ciena Posts Downbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2541600865","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541600865?lang=en_us&edition=fundamental","pubTime":"2025-06-06 02:31","pubTimestamp":1749148282,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/06/45800670/crude-oil-moves-higher-ciena-posts-downbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHPT","OMI","LIMN","PVH","CIEN","RGNX"],"gpt_icon":1},{"id":"2541907568","title":"Liminatus Pharma Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2541907568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541907568?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:35","pubTimestamp":1749130515,"startTime":"0","endTime":"0","summary":"09:33 EDT Liminatus Pharma (LIMN) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, marke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liminatus-pharma-inc-trading-halted-volatility-trading-pause-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2541075387","title":"Liminatus Pharma Shares Jump 75.4% After More Than Doubling in Value in the Last Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2541075387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541075387?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:35","pubTimestamp":1749130502,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL3N3S80Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2541044285","title":"Liminatus Pharma Shares Jump 80% Premarket After More Than Doubling in Value in the Last Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2541044285","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541044285?lang=en_us&edition=fundamental","pubTime":"2025-06-05 16:18","pubTimestamp":1749111531,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL3N3S80KC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2541097543","title":"Stocks to Watch: Verint, Liminatus, Five Below","url":"https://stock-news.laohu8.com/highlight/detail?id=2541097543","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541097543?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:32","pubTimestamp":1749079920,"startTime":"0","endTime":"0","summary":"Verint Systems beat Wall Street expectations with its first-quarter financial sales and adjusted earnings. Shares climbed 19% to $21.89 in postmarket trading Wednesday.Liminatus Pharma said it regained compliance with Nasdaq listing requirements. It filed its delayed 10-Q on Monday after receiving a noncompliance notice on May 29. Shares jumped 72% to $21.88 after the market closed.Five Below logged higher-than-expected sales in the first quarter, and said it expects its outperformance to continue into the second quarter. It raised its sales outlook for the full year, though new tariff costs are moderating other metrics. Shares advanced 4% to $125.75 after market close.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU1559883803.SGD","BK4200","LU0566484027.USD","BK4139","LIMN","VRNT","FIVE"],"gpt_icon":0},{"id":"2541099624","title":"Liminatus Pharma Achieves Compliance with Nasdaq Filing Requirements Following Recent Delay","url":"https://stock-news.laohu8.com/highlight/detail?id=2541099624","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541099624?lang=en_us&edition=fundamental","pubTime":"2025-06-05 04:31","pubTimestamp":1749069106,"startTime":"0","endTime":"0","summary":"Liminatus Pharma Inc., a biopharmaceutical company focused on developing immune-modulating cancer therapies, announced that it has resolved a regulatory compliance issue with Nasdaq. As of June 3, 2025, the company has met the requirements of Nasdaq Listing Rule 5250, which mandates the timely filing of reports with the U.S. Securities and Exchange Commission . This follows a notification from Nasdaq on May 29, 2025, indicating non-compliance due to a delay in filing their Quarterly Report on Form 10-Q for the period ending March 31, 2025. The company successfully filed the necessary report on June 2, 2025, restoring its compliance and closing the matter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL9JmQCz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2541709658","title":"Liminatus Pharma Shares Halted; Last up 107.5% at $11","url":"https://stock-news.laohu8.com/highlight/detail?id=2541709658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541709658?lang=en_us&edition=fundamental","pubTime":"2025-06-05 03:53","pubTimestamp":1749066820,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL2N3S70ZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LIMN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LIMN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-06","symbol":"LIMN","reason":null,"defaultRemindTime":1725629400000,"announcedDate":"2024-09-05","type":"delisting","dateTimestamp":1725595200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LIMN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LIMN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LIMN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LIMN","date":"2025-06-27","current":-121.782835,"percent":0.03321,"low":-195.659531,"twenty":-28.49778,"median":-17.503744,"eighty":-16.572225,"high":-8.670041,"avg":-29.237541,"sd":30.40072,"marketCap":431842907},"quantilePoints":[{"date":"2024-05-31","current":-29.356886,"twenty":-27.648492,"median":-26.153647,"eighty":-25.797732,"marketCap":85956962},{"date":"2024-06-07","current":-28.227775,"twenty":-27.609218,"median":-27.049572,"eighty":-26.224831,"marketCap":82650925},{"date":"2024-06-14","current":-27.12321,"twenty":-28.473234,"median":-27.160029,"eighty":-26.818841,"marketCap":79416758},{"date":"2024-06-21","current":-28.424142,"twenty":-28.841422,"median":-27.258212,"eighty":-27.034844,"marketCap":83225888},{"date":"2024-06-28","current":-28.645055,"twenty":-28.762875,"median":-28.227775,"eighty":-27.05939,"marketCap":83872721},{"date":"2024-07-05","current":-28.0805,"twenty":-28.645055,"median":-28.227775,"eighty":-27.083936,"marketCap":82219703},{"date":"2024-07-12","current":-27.442306,"twenty":-28.645055,"median":-28.092773,"eighty":-27.12321,"marketCap":80351073},{"date":"2024-07-19","current":-28.49778,"twenty":-28.645055,"median":-28.227775,"eighty":-27.137937,"marketCap":83441499},{"date":"2024-07-26","current":-27.098664,"twenty":-28.645055,"median":-28.092773,"eighty":-27.103573,"marketCap":79344888},{"date":"2024-08-02","current":-27.074118,"twenty":-28.6156,"median":-28.0805,"eighty":-27.074118,"marketCap":79273018},{"date":"2024-08-09","current":-16.785464,"twenty":-28.49778,"median":-27.761403,"eighty":-27.074118,"marketCap":79344888},{"date":"2024-08-16","current":-16.869239,"twenty":-28.49778,"median":-27.368669,"eighty":-27.074118,"marketCap":79740894},{"date":"2024-08-23","current":-15.964436,"twenty":-28.49778,"median":-27.160029,"eighty":-25.940098,"marketCap":75463888},{"date":"2024-08-30","current":-16.359746,"twenty":-28.49778,"median":-27.098664,"eighty":-16.869239,"marketCap":77332518},{"date":"2024-09-06","current":-16.800668,"twenty":-28.49778,"median":-27.098664,"eighty":-16.800668,"marketCap":79416758},{"date":"2024-09-13","current":-15.872679,"twenty":-28.424142,"median":-27.074118,"eighty":-16.724647,"marketCap":75030154},{"date":"2024-09-20","current":-16.325753,"twenty":-28.424142,"median":-27.074118,"eighty":-16.597597,"marketCap":77171833},{"date":"2024-09-27","current":-16.189831,"twenty":-28.227775,"median":-27.074118,"eighty":-16.526992,"marketCap":76529329},{"date":"2024-10-04","current":-16.688212,"twenty":-28.227775,"median":-27.074118,"eighty":-16.344693,"marketCap":78885176},{"date":"2024-10-11","current":-16.688212,"twenty":-28.227775,"median":-26.767294,"eighty":-16.359746,"marketCap":78885176},{"date":"2024-10-18","current":-16.824134,"twenty":-28.105045,"median":-25.797732,"eighty":-16.496584,"marketCap":79527680},{"date":"2024-10-25","current":-16.899646,"twenty":-28.0805,"median":-16.899646,"eighty":-16.526992,"marketCap":79884626},{"date":"2024-11-01","current":-16.899646,"twenty":-28.0805,"median":-16.899646,"eighty":-16.587809,"marketCap":79884626},{"date":"2024-11-08","current":-16.763724,"twenty":-28.0805,"median":-16.899646,"eighty":-16.587809,"marketCap":79242123},{"date":"2024-11-15","current":-16.522085,"twenty":-28.0805,"median":-16.869239,"eighty":-16.522085,"marketCap":78099894},{"date":"2024-11-22","current":-16.572225,"twenty":-28.0805,"median":-16.837108,"eighty":-16.522085,"marketCap":78336906},{"date":"2024-11-29","current":-16.572225,"twenty":-27.569945,"median":-16.824134,"eighty":-16.522085,"marketCap":78336906},{"date":"2024-12-06","current":-16.748621,"twenty":-27.442306,"median":-16.824134,"eighty":-16.522085,"marketCap":79170733},{"date":"2024-12-13","current":-17.05067,"twenty":-27.383396,"median":-16.824134,"eighty":-16.526011,"marketCap":80598519},{"date":"2024-12-20","current":-17.201695,"twenty":-27.329395,"median":-16.850082,"eighty":-16.563178,"marketCap":81312412},{"date":"2024-12-27","current":-17.201695,"twenty":-27.245939,"median":-16.869239,"eighty":-16.572225,"marketCap":81312412},{"date":"2025-01-03","current":-16.944953,"twenty":-27.167392,"median":-16.899646,"eighty":-16.572225,"marketCap":80098794},{"date":"2025-01-10","current":-16.944953,"twenty":-27.12321,"median":-16.899646,"eighty":-16.572225,"marketCap":80098794},{"date":"2025-01-17","current":-17.503744,"twenty":-27.118301,"median":-16.899646,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-01-24","current":-17.503744,"twenty":-27.098664,"median":-16.9223,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-01-31","current":-17.503744,"twenty":-27.098664,"median":-16.944953,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-07","current":-20.239774,"twenty":-27.098664,"median":-16.944953,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-14","current":-20.239774,"twenty":-27.074118,"median":-16.944953,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-21","current":-20.239774,"twenty":-27.074118,"median":-16.975158,"eighty":-16.572225,"marketCap":82740198},{"date":"2025-02-28","current":-20.414406,"twenty":-27.074118,"median":-17.05067,"eighty":-16.572225,"marketCap":83454091},{"date":"2025-03-07","current":-26.194704,"twenty":-27.074118,"median":-17.05067,"eighty":-16.584692,"marketCap":107083950},{"date":"2025-03-14","current":-26.194704,"twenty":-27.074118,"median":-17.201695,"eighty":-16.587809,"marketCap":107083950},{"date":"2025-03-21","current":-26.194704,"twenty":-27.074118,"median":-17.201695,"eighty":-16.595639,"marketCap":107083950},{"date":"2025-03-28","current":-15.716822,"twenty":-27.074118,"median":-17.201695,"eighty":-16.587809,"marketCap":64250370},{"date":"2025-04-04","current":-15.716822,"twenty":-27.074118,"median":-17.201695,"eighty":-16.572225,"marketCap":64250370},{"date":"2025-04-11","current":-15.716822,"twenty":-27.074118,"median":-17.05067,"eighty":-16.572225,"marketCap":64250370},{"date":"2025-04-17","current":-12.11383,"twenty":-27.074118,"median":-17.05067,"eighty":-16.554132,"marketCap":49521339},{"date":"2025-04-25","current":-9.258427,"twenty":-27.05939,"median":-16.998323,"eighty":-16.522085,"marketCap":37848451},{"date":"2025-05-02","current":-51.163808,"twenty":-27.074118,"median":-17.05067,"eighty":-16.522085,"marketCap":209157649},{"date":"2025-05-09","current":-54.655673,"twenty":-27.074118,"median":-17.05067,"eighty":-16.522085,"marketCap":193809015},{"date":"2025-05-16","current":-47.319341,"twenty":-27.098664,"median":-17.201695,"eighty":-16.522085,"marketCap":167794382},{"date":"2025-05-23","current":-40.349825,"twenty":-27.152665,"median":-17.201695,"eighty":-16.525029,"marketCap":143080481},{"date":"2025-05-30","current":-38.295653,"twenty":-27.412851,"median":-17.201695,"eighty":-16.545085,"marketCap":135796384},{"date":"2025-06-06","current":-180.473765,"twenty":-28.0805,"median":-17.201695,"eighty":-16.572225,"marketCap":639959971},{"date":"2025-06-13","current":-149.000565,"twenty":-28.178683,"median":-17.503744,"eighty":-16.572225,"marketCap":528357196},{"date":"2025-06-20","current":-93.904837,"twenty":-28.384869,"median":-17.503744,"eighty":-16.572225,"marketCap":332987302},{"date":"2025-06-27","current":-121.782835,"twenty":-28.49778,"median":-17.503744,"eighty":-16.572225,"marketCap":431842907}],"updateTime":1751107694632}}}